Northland analyst Tim Savageaux raised the firm’s price target on Kyivstar (KYIV) to $19 from $17 and keeps an Outperform rating on the shares following the acquisition of Tabletki.ua, which the firm calls “the leading provider of consumer digital pharma services in Ukraine,” along with a positive guidance update in late January.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KYIV:
- Kyivstar Group Buys Tabletki.ua for $160 Million to Deepen Digital Healthcare Push in Ukraine
- Kyivstar acquires Tabletki.ua for $160M
- Kyivstar Group Shareholders Price USD 10.50 Secondary Offering on Nasdaq
- Kyivstar 12.5M share Secondary priced at $10.50
- Kyivstar Group Backs Secondary Share Offering With Strong 2025 Preliminary Growth